Multiple myeloma epidemiology and demographics

Multiple myeloma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multiple Myeloma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Multiple myeloma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Multiple myeloma epidemiology and demographics All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Multiple myeloma epidemiology and demographics
CDC on Multiple myeloma epidemiology and demographics
Multiple myeloma epidemiology and demographics in the news
Blogs on Multiple myeloma epidemiology and demographics
Directions to Hospitals Treating Multiple myeloma
Risk calculators and risk factors for Multiple myeloma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Multiple myeloma is the second most common blood cancer after non-Hodgkin's lymphoma & 15th most common cancer overall in United States. Multiple myeloma is a disease of the elderly and is slightly more prevalent in men than women. The average survival of multiple myeloma patients is approximately 3 years and approximately 43.5% of patients survive after 5 years. It is estimated that 77,617 people currently live with multiple myeloma in the United States.

Epidemiology and Demographics

Prevalance

There are approximately 76,000 people in the United States living with multiple myeloma, and the American Cancer Society estimates that approximately 14,600 new cases of multiple myeloma are diagnosed each year in the United States. The average survival of multiple myeloma patients is approximately 3 years.

Age

Multiple myeloma is the second most prevalent blood cancer (10%) after non-Hodgkin's lymphoma. It represents approximately 1% of all cancers and 2% of all cancer deaths. Although the peak age of onset of multiple myeloma is 65 to 70 years of age, recent statistics report increasing incidence as well as earlier age of onset of multiple myeloma.

Gender

Multiple myeloma affects slightly more men than women.

Race

African Americans and non Hispanics have the highest reported incidence of multiple myeloma in the United States while Asians and American Indians have the lowest. Results of a recent study report the incidence of myeloma to be 12.3 cases per 100,000 among African Americans and 5.6 cases per 100,000 among Caucasian Americans. Among African Americans, multiple myeloma is one of the top 10 leading causes of cancer death.